ON DEMAND: 15th Annual Yale Digestive Disease Week Review

Thursday, June 10, 2021, 2:08 PM - Sunday, June 9, 2024, 3:08 PM

This course is a unique opportunity for a panel of experts in subspecialty areas within gastroenterology to present the most important new information presented at Digestive Disease Week and within the past year. This course is a valuable experience for those who have attended Digestive Disease Week in addition to those who have not. We are pleased to bring the 15th Annual Yale Digestive Disease Week Review to the regional gastroenterology community.

 

Lecture Topics:

Esophageal and Gastric Motility
Lower GI Tract Disease                     
GI Bleeding    
COVID-19 and the Gastroenterologist
Inflammatory Bowel Disease (IBD)
IBD Patient Cases
Acute and Chronic pancreatitis
ERCP
Endoscopic Ultrasound

1. Identify therapeutic options for patients with complex inflammatory bowel disease
2. Review the impacts of Covid 19 on the gastrointestinal tract
3. Discuss new developments in the diagnosis and treatment of esophageal and gastric motility disorders
4. Assess endoscopic diagnosis and treatment of pancreaticobiliary disorders
5. Translate information learned from presentations to the patient’s bedside
6. Assess the different measures that have been shown to improve adenoma detection during colon cancer screening
7. Identify optimal therapy for gastrointestinal bleeding disorders
8. Apply recent developments and new technologies in gastroenterology and hepatology to their practice
9. Discuss controversial and novel findings as presented at DDW

Complimentary

The Yale School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement
The Yale School of Medicine designates this enduring material for a maximum of 4.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Policy
It is the policy of Yale School of Medicine, Continuing Medical Education (CME), to ensure balance, independence, objectivity, and scientific rigor in all its educational programs.  All individuals involved in the development and presentation of Accredited Continuing Education activities are required to disclose all financial relationship(s) with ineligible companies that has occurred within the past 24 months; and the opportunity to affect the content of CME about the products or services of the commercial interests. This information is disclosed to all activity participants prior to the commencement of the educational activity.

AMA PRA Category 1 Credits™ (4.00 hours), Non-Physician Attendance (4.00 hours)

Mitigation of Relevant Financial Relationships

Yale Continuing Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.